Mortality from Parkinson's disease in England and Wales was re-examined using published government statistics. The 300% increase in the crude mortality rate between 1921 and 1989 was largely attributable to the increase in the elderly population who suffer a higher prevalence of the disease. The dramatic fall in 1940 and rise in 1984 were artefacts caused by changes in certification. Agespecific mortality fell after 1940 in all groups below 70 years and in both sexes, but increased in those over 75 years. Analysis by birth cohort showed a progressive decline in mortality at younger ages with successive cohorts but stable mortality in the elderly. Younger patients were probably misclassified cases of "late-onset" Parkinsonism following encephalitis lethargica who can be differentiated from older cases of idiopathic Parkinson's disease. Mortality decreased in all age groups in the 1970s but then increased in the early 1980s. This is comparable to trends in the United States and Scandinavia and suggests that the beneficial effects of levodopa delay death for several years.
The progressive increase in the age of onset of Parkinson' In 1984, the OPCS adopted the WHO rule 3 in which chronic conditions listed on the death certificate were taken as the cause of death. To allow for this, dual classification was performed for 1984 and a correction factor published (correction factor = 0-585; mortality statistics, cause, 1984; series DH2; No 11). This has been applied to 1984 and all subsequent years in fig 1.
Age-specific mortality rates were calculated for successive five year age bands over the age of 50 years, mortality below this age being negligible. These figures were then used as the source for cohort analysis. Standardisation of crude mortality rates was performed by applying the age-specific rates in each year to the population data for 1921. The calculated mortality was then divided by the true mortality in 1921 and multiplied by 100 to produce a standardised mortality ratio (SMR). to all subsequent years (dotted line).
Results
The crude mortality rate for Parkinso: 8 and 85% of cases in two reviews taking data Interpretation is also made multiple confounding variables a same time. Thus the increase ir population over the period of study will lead to an increase in idiopathic Parkinson's disease v higher prevalence in this age gro trast, the introduction of levoc 1970s will cause a reduction i Adequate allowances must be mi the above difficulties when ati draw any conclusions from these 4 The overall trend in crude m( 1921 to 1989 suggests that ( Parkinson's disease have risen by 300% (fig 1) . However, if changes in the age structure of the population are allowed for by applying age-specific mortality rates to the population of 1921 and calculating a standardised mortality ratio (fig 3) then the increase is reduced to only 20% in women and 60% in men. This less marked rise may be consistent with improvements in the diag-/| nosis of the condition and in the quality of death certification rather than any increase in the aetiological factor(s) responsible for the disease. Nevertheless, the scale of the increment in Parkinson's disease mortality due to the changing age structure of the population is considerable and has wide ranging implications with regard to the provision of health 1980 1990 care in the future.
Commencing around 1940, age-specific England and death rates showed a sustained fall in mortalsee text.
ity in younger age groups compared with an increase in those over 75 years (fig 2) . Identical trends have been reported from United States.'2 13 Analysis of mortality by birth cohort is more complex. Taking the udy of death peak age of occurrence of encephalitis letharmesota only gica as between 20 and 40 years and the dates I the diagno-of the major outbreaks between 1918 and 1926,5 the possible birth years of affected rtificates are patients extend from 1878 to 1906. These .er problems. birth years cover the majority of patients in actual fall in table 1 so it is unlikely that a clear peak in rminal event one birth year will occur. Nevertheless, a (that is, part decline in deaths at younger ages with succesites) and by sive birth cohorts did occur in keeping with rule 3 was age-specific mortality data. This continues to to the old be consistent with the two disease hypothesis -onditions as of Duvoisin and In conclusion, Parkinson's disease mortality between 1960 and 1989 in England and Wales must be explained by a number of variables. Throughout this period, there has been a progressive rise in mortality because of the ageing of the population. The large group of younger patients with post-encephalitic Parkinsonism largely died out during these decades leading to the plateau in the mortality curve. Levodopa deferred the deaths of an increasing proportion of patients with a progressive reduction in overall mortality in the 1970s. However, these patients died a mean of five years later leading to the abrupt rise in mortality in the early 1980s. The attenuating effects of the latter two variables have now waned and the steady rise in the mid to late 1980s is once again due to the changing age structure of the population.
